Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-09

Clinical Trial Update: Melatonin in ADHD and Sleep Problems [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on melatonin for Attention Deficit Hyperactivity Disorder and sleep disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Allan Hvolby | Conditions: Attention Deficit Hyperactivity Disorder, Sleep Disorder | Phase 4 | Status: UNKNOWN